CTN :42904123
23 Dec, 2025
90.00 Crore
Tender For e-bid for rate contract cum supply and empanelment of firms for drugs and medicines - dexamethasone inj ip 8mg/2ml [39], surgical spirit ip (500 ml) [252], biphasic isophane insulin inj ip (30 % soluble insulin and 70 % isophane insulin) inj. 40 iu/ml(r-dna origin) [279], calcium and an cl
ass="text-red-selected">vit
aminan> d3 suspension (e
ach 5 ml cont
ains c
alcium c
arbon
ate equiv
alent to element
al c
alcium 250 mg,
an class="text-red-selected">vitaminan> d3 125 iu) [441], surf
act
ant for intr
atreche
al instill
ation (n
atur
al bovine lung surf
act
ant) [635], dried f
actor viii fr
action ip (iv use) 500 iu/vi
al [688], recombin
ant f ix 500 iu with diluent [748], 3rd gener
ation recombin
ant f viii 1000 iu with diluent [750], leurprolide
acet
ate depot 3.75 mg [775], g
atiflox
acin 0.30%
and prednisolone
acet
ate 1% ophth
almic suspension [nrd-103], hpmc 0.3% eye drop [nrd-104], voricon
azole 1 % w/v (lyophilized) 30mg eye drop [nrd-119], chlor
amphenicol 1%, polymyxin b sulph
ate (10000 units)
and dex
ameth
asone 0.1% sodium phosph
ate eye ointment [nrd-123], c
armustine 100 mg inj. ip [nrd-175], detemir insuline 100iu/ml injection 3ml [nrd-214], flud
ar
abine phosph
ate injection 100mg inj. ip [nrd-237], flud
ar
abine phosph
ate injection 50mg inj. ip [nrd-238], methotrex
ate 1000 mg inj. ip [nrd-289], inj. methylprednisolone
acet
ate 125 mg i.p. (e
ach vi
al cont
ains methylprednisolone
acet
ate 125 mg) [nrd-292], mitomycin 40 mg inj. ip [nrd-297], plerix
afor 24 mg inj. [nrd-338], r
asburic
ase 1.5 mg inj. [nrd-347], recombin
ant lh 75iu inj. [nrd-351], tr
abectedin 1 mg inj. [nrd- 387], tryp
an blue 0.06% w/v injection [nrd-393], levos
albut
amol 50mcg.
and ipr
atropium 40mcg. mdi [nrd-425], glycopyrronium inh
al
ation solution 25mcg 2 ml [nrd-458],
amorolfine 0.25% cre
am [nrd-46], glycolic
acid 6% cre
am [nrd-51], hydroquinone 2% cre
am usp [nrd-53], everolimus 10mg t
ab./c
ap. [nrd-531], d
acomitinib 15 mg t
ab., methim
azole 10mg t
ab. usp [nrd-678], r
as
agiline1mg t
ab. [nrd-756], regor
afenib 40 mg t
ab. [nrd- 757], uliprist
al 5mg t
ab. [nrd-808], brinozol
amide 1% w/v
and brimonidine t
artr
ate 0.2% w/v ophth
almic suspension [nrd-98], triclofos or
al suspension500 mg/ 5ml in 30ml syrup i.p.[nrd-522], etoricoxib+thiocolchicoside(60+8 mg) t
ab. [nrd-630], levodop
a and c
arbidop
a and ent
ac
apone 100mg/25mg/200mg t
ab. [nrd-662], nicor
andil 5mg t
ab. i.p. [nrd-704], nifidipine c
apsule 10mg, di
ast
ase, pepsin with simethicone 15ml drope
ach ml cont
ains di
ast
ase (1:1200) 33.33mg, pepsin (1:3000) 5mg&
amp; simethicone emulsion 40mg [nrd-71], nit
azox
anide 500mg t
ab.[nrd-713], hydroxyzine hydrochloride or
al solution / drop 6mg/ml [nrd-76], trimet
azidine hydrochloride modified rele
ase (cr/sr/pr) 60 mg c
apsule/t
ablet [nrd-805], ferrous
ascorb
ate
and folic
acid drops 15ml (e
ach ml cont
ains ferrous
ascorb
ate 10mg
and folic
acid 100mcg) [nrd-81], zinc 50mg t
ab. [nrd-818],
an class="text-red-selected">vitaminan> e 50mg/ml drops 15ml [nrd-83], glycopegyl
ated extended h
alf life f
actor viii 1000 iu